Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination
We are sorry, but NCBI web applications do not support your browser and may not function properly. More information

Results: 1 to 20 of 135

1.

Influence of oral contraceptives on anthropomorphometric, endocrine, and metabolic profiles of anovulatory polycystic ovary syndrome patients.

Mes-Krowinkel MG, Louwers YV, Mulders AG, de Jong FH, Fauser BC, Laven JS.

Fertil Steril. 2014 Mar 25. pii: S0015-0282(14)00192-7. doi: 10.1016/j.fertnstert.2014.02.039. [Epub ahead of print]

PMID:
24680368
[PubMed - as supplied by publisher]
2.

Predicting menopausal age with anti-Müllerian hormone: a cross-validation study of two existing models.

Ramezani Tehrani F, Dólleman M, van Disseldorp J, Broer SL, Azizi F, Solaymani-Dodaran M, Fauser BC, Laven JS, Eijkemans MJ, Broekmans F.

Climacteric. 2014 Mar 14. [Epub ahead of print]

PMID:
24625203
[PubMed - as supplied by publisher]
3.

BMI-associated alleles do not constitute risk alleles for polycystic ovary syndrome independently of BMI: a case-control study.

Louwers YV, Rayner NW, Herrera BM, Stolk L, Groves CJ, Barber TM, Uitterlinden AG, Franks S, Laven JS, McCarthy MI.

PLoS One. 2014 Jan 31;9(1):e87335. doi: 10.1371/journal.pone.0087335. eCollection 2014.

PMID:
24498077
[PubMed - in process]
Free PMC Article
4.

Anti-Mullerian hormone is a more accurate predictor of individual time to menopause than mother's age at menopause.

Dólleman M, Depmann M, Eijkemans MJ, Heimensem J, Broer SL, van der Stroom EM, Laven JS, Van Rooij IA, Scheffer GJ, Peeters PH, van der Schouw YT, Lambalk CB, Broekmans FJ.

Hum Reprod. 2014 Mar;29(3):584-91. doi: 10.1093/humrep/det446. Epub 2014 Jan 15.

PMID:
24435779
[PubMed - in process]
5.

Can magnetic resonance imaging at 3.0-Tesla reliably detect patients with endometriosis? Initial results.

Thomeer MG, Steensma AB, van Santbrink EJ, Willemssen FE, Wielopolski PA, Hunink MG, Spronk S, Laven JS, Krestin GP.

J Obstet Gynaecol Res. 2014 Apr;40(4):1051-8. doi: 10.1111/jog.12290. Epub 2014 Jan 15.

PMID:
24428703
[PubMed - in process]
6.

Decreased serum anti-Müllerian hormone levels in girls with newly diagnosed cancer.

van Dorp W, van den Heuvel-Eibrink MM, de Vries AC, Pluijm SM, Visser JA, Pieters R, Laven JS.

Hum Reprod. 2014 Feb;29(2):337-42. doi: 10.1093/humrep/det442. Epub 2013 Dec 16.

PMID:
24345579
[PubMed - in process]
7.

The M-OVIN study: does switching treatment to FSH and / or IUI lead to higher pregnancy rates in a subset of women with world health organization type II anovulation not conceiving after six ovulatory cycles with clomiphene citrate - a randomised controlled trial.

Nahuis MJ, Weiss NS, van der Veen F, Mol BW, Hompes PG, Oosterhuis J, Lambalk NB, Smeenk JM, Koks CA, van Golde RJ, Laven JS, Cohlen BJ, Fleischer K, Goverde AJ, Gerards MH, Klijn NF, Nekrui LC, van Rooij IA, Hoozemans DA, van Wely M.

BMC Womens Health. 2013 Oct 25;13:42. doi: 10.1186/1472-6874-13-42.

PMID:
24160333
[PubMed - indexed for MEDLINE]
Free PMC Article
8.

Comparison of early versus late initiation of GnRH antagonist co-treatment for controlled ovarian stimulation in IVF: a randomized controlled trial.

Hamdine O, Macklon NS, Eijkemans MJ, Laven JS, Cohlen BJ, Verhoeff A, van Dop PA, Bernardus RE, Lambalk CB, Oosterhuis GJ, Holleboom CA, van den Dool-Maasland GC, Verburg HJ, van der Heijden PF, Blankhart A, Fauser BC, Broekmans FJ; CETRO trial study group.

Hum Reprod. 2013 Dec;28(12):3227-35. doi: 10.1093/humrep/det374. Epub 2013 Oct 15.

PMID:
24129613
[PubMed - in process]
9.

Cross-ethnic meta-analysis of genetic variants for polycystic ovary syndrome.

Louwers YV, Stolk L, Uitterlinden AG, Laven JS.

J Clin Endocrinol Metab. 2013 Dec;98(12):E2006-12. doi: 10.1210/jc.2013-2495. Epub 2013 Oct 8.

PMID:
24106282
[PubMed - indexed for MEDLINE]
10.

Letter to the editor: gonadal function after childhood ovarian surgery.

van Dorp W, Pieters R, van den Heuvel-Eibrink MM, Laven JS, van Dorp W, van de Ven CP.

J Pediatr Surg. 2013 Sep;48(9):1990-1. doi: 10.1016/j.jpedsurg.2013.06.032. No abstract available.

PMID:
24074685
[PubMed - in process]
11.

The role of vitamin D in metabolic disturbances in polycystic ovary syndrome: a systematic review.

Krul-Poel YH, Snackey C, Louwers Y, Lips P, Lambalk CB, Laven JS, Simsek S.

Eur J Endocrinol. 2013 Oct 23;169(6):853-65. doi: 10.1530/EJE-13-0617. Print 2013 Dec. Review.

PMID:
24044903
[PubMed - indexed for MEDLINE]
Free Article
12.

Increased risk for ovarian cancer and borderline ovarian tumours in subfertile women with endometriosis.

Buis CC, van Leeuwen FE, Mooij TM, Burger CW; OMEGA Project Group.

Hum Reprod. 2013 Dec;28(12):3358-69. doi: 10.1093/humrep/det340. Epub 2013 Sep 5.

PMID:
24014607
[PubMed - in process]
13.

A universal method for sequential immunofluorescent analysis of chromatin and chromatin-associated proteins on chromosome spreads.

van de Werken C, Jahr H, Avo Santos M, Eleveld C, Schuilwerve J, Laven JS, Baart EB.

Chromosome Res. 2013 Aug;21(5):475-89. doi: 10.1007/s10577-013-9373-9. Epub 2013 Jul 30.

PMID:
23896649
[PubMed - indexed for MEDLINE]
14.

Characteristics and outcome of pediatric non-Hodgkin lymphoma patients with ovarian infiltration at presentation.

van Dorp W, Owusuaa C, Laven JS, van den Heuvel-Eibrink MM, Beishuizen A.

Pediatr Blood Cancer. 2013 Dec;60(12):2054-9. doi: 10.1002/pbc.24582. Epub 2013 Jul 19.

PMID:
23868611
[PubMed - indexed for MEDLINE]
15.

Variants in SULT2A1 affect the DHEA sulphate to DHEA ratio in patients with polycystic ovary syndrome but not the hyperandrogenic phenotype.

Louwers YV, de Jong FH, van Herwaarden NA, Stolk L, Fauser BC, Uitterlinden AG, Laven JS.

J Clin Endocrinol Metab. 2013 Sep;98(9):3848-55. doi: 10.1210/jc.2013-1976. Epub 2013 Jul 16.

PMID:
23861462
[PubMed - indexed for MEDLINE]
16.

Early initiation of gonadotropin-releasing hormone antagonist treatment results in a more stable endocrine milieu during the mid- and late-follicular phases: a randomized controlled trial comparing gonadotropin-releasing hormone antagonist initiation on cycle day 2 or 6.

Hamdine O, Broekmans FJ, Eijkemans MJ, Lambalk CB, Fauser BC, Laven JS, Macklon NS; CETRO trial study group.

Fertil Steril. 2013 Sep;100(3):867-74. doi: 10.1016/j.fertnstert.2013.05.031. Epub 2013 Jun 27.

PMID:
23809501
[PubMed - indexed for MEDLINE]
17.

Bone morphogenetic proteins and the polycystic ovary syndrome.

van Houten EL, Laven JS, Louwers YV, McLuskey A, Themmen AP, Visser JA.

J Ovarian Res. 2013 Apr 30;6(1):32. doi: 10.1186/1757-2215-6-32.

PMID:
23627969
[PubMed]
Free PMC Article
18.

Human embryonic growth trajectories and associations with fetal growth and birthweight.

van Uitert EM, Exalto N, Burton GJ, Willemsen SP, Koning AH, Eilers PH, Laven JS, Steegers EA, Steegers-Theunissen RP.

Hum Reprod. 2013 Jul;28(7):1753-61. doi: 10.1093/humrep/det115. Epub 2013 Apr 7.

PMID:
23569080
[PubMed - indexed for MEDLINE]
19.

Decreased ovarian function is associated with obesity in very long-term female survivors of childhood cancer.

van Dorp W, Blijdorp K, Laven JS, Pieters R, Visser JA, van der Lely AJ, Neggers SJ, van den Heuvel-Eibrink MM.

Eur J Endocrinol. 2013 May 7;168(6):905-12. doi: 10.1530/EJE-13-0114. Print 2013 Jun.

PMID:
23557987
[PubMed - indexed for MEDLINE]
20.

Levels of serum anti-Müllerian hormone, a marker for ovarian reserve, in women with rheumatoid arthritis.

Brouwer J, Laven JS, Hazes JM, Schipper I, Dolhain RJ.

Arthritis Care Res (Hoboken). 2013 Sep;65(9):1534-8. doi: 10.1002/acr.22013.

PMID:
23554429
[PubMed - indexed for MEDLINE]

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk